INS and Insulin resistance: A switch from boosted PIs (DRV, ATV, and LPV) to INSTIs (RAL and DTG) regimens has shown an improvement in insulin sensitivity, reduction of insulin (and homeostatic model assessment—insulin resistance (HOMA-IR)) and leptin levels.